Abstract Dibenzoazecines are a new class of drug candidates for the treatment schizophrenia. Compared to drugs currently used in therapy, azecines have novel mechanism action. Thus, they potential cause fewer side effects compared standard therapy with constant high neuroleptic potency. This theory was substantiated by comparative vivo tests haloperidol and risperidone. Seventeen azecine deriva...